Topic: Geron Corporation
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs, and the company will focus instead on new cancer treatments, Geron said Tuesday.The California-based biotech firm, which had bypassed federal funding to get its ...
LONDON (Reuters) - A decision by one of the biggest names in stem cell research to throw in the towel will not stop other pioneering work that could yet produce cures for blindness and help mend broken hearts.Scientists were shocked by U.S. ...
Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on humans suffering from spinal cord injury and blindness.The potent but hotly debated cells can transform into nearly any cell in ...
Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on humans suffering from spinal cord injury and blindness.The potent but hotly debated cells can transform into nearly any cell in ...
During October 2010 the first patient was recruited to take part in a US clinical trial involving the use of human embryonic stem cell derived transplants to repair spinal cord damage.. Stem cells cause regeneration of neural tissue . Stem cells are ...
In October 2010, the first human clinical trials began for a drug based on human embryonic stem cell research . In Geron's case, the stem cells have been altered so that they become nerve cells, and will then be sent to the ...
The first patient to be treated in a U.S.-government-approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells.. The current Phase I trial, sponsored by Geron Corp. of Menlo Park, Calif., is mainly looking ...
Science: After decades of promises, the first clinical trial using human embryonic stem cells has begun. The announcement by Geron Corp. on Monday that the first clinical trial using its embryonic stem cells to treat an actual human patient was under way ...
Geron, a California company developing therapies derived from embryonic stem cells, announced on Monday that the first patient has been treated in its landmark trial for spinal cord injury. Geron researchers have also developed a way to reliably freeze and thaw brain ...
CHICAGO (Reuters) - Only eight people will take part in the first known clinical trial testing the safety of embryonic stem cells in humans and each patient will go through a very stringent selection process, the lead researcher of the study said ...
From Around the Web
Video Gallery
-
GERON is trending up post hitting ...
Robert Weinstein of Paid2Trade.com talks with Curtis Hollister about ...2012-01-31 -
GERON is trending up post hitting ...
Robert Weinstein of Paid2Trade.com talks with Curtis Hollister about ...2012-01-31 -
Geron's Embryonic Stem Cell Clinical ...
Dr. Jane Lebkowski, executive vice president and chief scientific officer ...2011-07-29
